Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Safety and Pharmacokinetics/Pharmacodynamics Study of Oral L-CIT Supplementation in Preterm Infants With BPD±PH and NEC

NCT05636397 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT05636397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05636397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Safety and Pharmacokinetics/Pharmacodynamics Study of Oral L-CIT Supplementation in Preterm Infants With BPD±PH and NEC
Lead sponsor
The Hospital for Sick Children
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
March 31, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bpd - bronchopulmonary dysplasia, nec, pulmonary hypertension